Literature DB >> 26722605

Correlation between BOLD-MRI and HIF expression level in renal carcinoma.

Dong Li1, Xingming Wang1, Shuai Wang1, Jie Cheng2.   

Abstract

Occupying about 2%~3% of all malignant tumors, renal carcinoma is the most common primary cancer in kidney. The oxidative level of tumor cells is of vital role for optimizing treatment plan, evaluating efficacy and predicting prognosis. This study thus investigated the R2(*) value in mouse renal carcinoma model and the correlation between tumor hypoxia and expression level of hypoxia inducible factor-1 (HIF-1). A total of 20 BALB/C nude mice (4~6 weeks old) were inoculated with human ACHN renal carcinoma cells to generate renal cancer model. After the tumor diameter reached 0.5 cm, all animals were examined by BOLD-MRI, both under normal inhalation (R2a(*)) and carbogen treatment (R2b(*)). The alternation of R2(*) values (ΔR2(*)=R2a(*) - R2b(*)) was calculated. Mice were then sacrificed for Immunohistochemical (IHC) staining targeting HIF-1α and HIF-2α. The positive score of HIF was then analyzed for its correlation with R2(*) value. In 18 mice finished both experiments, Pearson correlation analysis revealed significant negative correlation between R2a(*) and ΔR2(*) (r=-0.48, P<0.05) and positive relationship between ΔR2(*) and HIF-2α (r=0.38, P<0.05). HIF-1α level, however, did not correlated with tumor R(*) values. The positive correlation between ΔR2(*) and HIF-2α, but not HIF-1α, suggested potential role of combined BOLD-MRI technique and HIF-1α staining in clinical diagnosis of renal carcinoma. HIF-2α may work as biological marker for renal cancer.

Entities:  

Keywords:  BOLD-MIR; Renal carcinoma; correlation analysis; hypoxia inducible factor

Mesh:

Substances:

Year:  2015        PMID: 26722605      PMCID: PMC4680550     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

Authors:  M S Wiesener; P M Münchenhagen; I Berger; N V Morgan; J Roigas; A Schwiertz; J S Jürgensen; G Gruber; P H Maxwell; S A Löning; U Frei; E R Maher; H J Gröne; K U Eckardt
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 2.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

3.  Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

Authors:  M Krieg; R Haas; H Brauch; T Acker; I Flamme; K H Plate
Journal:  Oncogene       Date:  2000-11-16       Impact factor: 9.867

4.  Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

Authors:  Kevin J Turner; John W Moore; Adam Jones; Claire F Taylor; Darren Cuthbert-Heavens; Cheng Han; Russell D Leek; Kevin C Gatter; Patrick H Maxwell; Peter J Ratcliffe; David Cranston; Adrian L Harris
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

5.  HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D.

Authors:  A Toschi; J Edelstein; P Rockwell; M Ohh; D A Foster
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

6.  HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Authors:  Stefano J Mandriota; Kevin J Turner; David R Davies; Paul G Murray; Neil V Morgan; Heidi M Sowter; Charles C Wykoff; Eamonn R Maher; Adrian L Harris; Peter J Ratcliffe; Patrick H Maxwell
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

7.  The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function.

Authors:  L C J Baker; J K R Boult; S Walker-Samuel; Y-L Chung; Y Jamin; M Ashcroft; S P Robinson
Journal:  Br J Cancer       Date:  2012-04-12       Impact factor: 7.640

Review 8.  HIF and fumarate hydratase in renal cancer.

Authors:  S Sudarshan; W M Linehan; L Neckers
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

9.  The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.

Authors:  Guang-Yu Wu; Shi-Teng Suo; Qing Lu; Jin Zhang; Wan-Qiu Zhu; Jian-Rong Xu
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

10.  Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans.

Authors:  Menno Pruijm; Lucie Hofmann; Maciej Piskunowicz; Marie-Eve Muller; Carole Zweiacker; Isabelle Bassi; Bruno Vogt; Matthias Stuber; Michel Burnier
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

View more
  4 in total

1.  Comparison of phosphorescent agents for noninvasive sensing of tumor oxygenation via Cherenkov-excited luminescence imaging.

Authors:  Jennifer Shell; Ethan P LaRochelle; Petr Bruza; Jason Gunn; Lesley Jarvis; David Gladstone; Brian Pogue
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

Review 2.  The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.

Authors:  Bernard Gallez
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

3.  The Blood Oxygenation T2* Values of Resectable Esophageal Squamous Cell Carcinomas as Measured by 3T Magnetic Resonance Imaging: Association with Tumor Stage.

Authors:  Yu-Lian Tang; Xiao-Ming Zhang; Zhi-Gang Yang; Yu-Cheng Huang; Tian-Wu Chen; Yan-Li Chen; Fan Chen; Nan-Lin Zeng; Rui Li; Jiani Hu
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

4.  Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI.

Authors:  Johannes Linxweiler; Christina Körbel; Andreas Müller; Eva Jüngel; Roman Blaheta; Joana Heinzelmann; Michael Stöckle; Kerstin Junker; Michael D Menger; Matthias Saar
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.